• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The role of bursal nonapeptide (BP9) on AIV vaccine immune response in chick immunization and on avian immature B cell

tetano

Editor, Senior Moderator
Protein Pept Lett. 2019 Jul 29. doi: 10.2174/0929866526666190730101455. [Epub ahead of print]
[h=1]The role of bursal nonapeptide (BP9) on AIV vaccine immune response in chick immunization and on avian immature B cell.[/h] Zheng Y[SUP]1[/SUP], Zong MM[SUP]1[/SUP], Chen BY[SUP]1[/SUP], Zhou XH[SUP]1[/SUP], Liu ZN[SUP]1[/SUP], Zhou GF[SUP]1[/SUP], Chen PY[SUP]1[/SUP], Feng XL[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] [h=4]BACKGROUND:[/h] Bursa of Fabricius plays the vital functions on B cell development and antibody production in poultry. The bursal-derived peptide plays the essential roles on avian immature B cell development.
[h=4]OBJECTIVES:[/h] Here we explored the functions of the recently reported bursal nonapeptide (BP9) on the antibody production and the molecular basis of BP9 on avian immature B cell.
[h=4]METHODS:[/h] Chicken were twice immunized with Avian Influenza Virus (AIV) inactivated vaccine plus with BP9 at three dosages, respectively. On two weeks after the second immunization, sera samples were collected from all experimental groups to measure AIV-specific Agglutination Inhibition (HI) antibody titers. Also, on 7th day after the second immunization, spleen lymphocytes were isolated from the immunized chicken to detect the lymphocyte viabilities. DT40 cells were treated with BP9 from 0.02 to 2 μg/mL for 4 and 20h to detect sIgM mRNA levels, and total RNAs from BP9-treated DT40 cells were collected to investigate the gene expression profiles of DT40 cells, and to analyze the enriched pathways and functional biological processes. Finally, nine gene expressions were validated with quantitative PCR (qPCR).
[h=4]RESULTS:[/h] Our investigation proved the strong regulatory roles of BP9 on AIV-specific HI antibody titers and lymphocyte viabilities. BP9 promoted sIgM mRNA levels in DT40 cells, and upregulated 598 gene expressions and downregulated 395 gene expressions in DT40 cells with 0.2μg/mL BP9 treatment. Moreover, our findings verified the significantly enriched six pathways and various the biological functional processes of BP9 on avian immature B cell. Also, we found eight signaling pathways in the enriched biological processes of BP9-treated DT40 cells, and the expressions of nine selected genes with qPCR were identical to that of microarray data.
[h=4]CONCLUSION:[/h] BP9 promoted the antibody production in the 21-old-day chicken immunization, and stimulated the sIgM expression in DT40 cells. Furthermore, we analyzed the gene expression profile and immune-related biological processes of DT40 cells treated with BP9, which provided some new insights into the mechanism on immature B cell development, and provide important references for adjuvant development on vaccine improvement and clinical application.
Copyright? Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.


[h=4]KEYWORDS:[/h] AIV inactivated vaccine; Antibody response; Bursal nonapeptide (BP9); DT40 cells; The enriched pathways; The functional biological processes

PMID: 31362650 DOI: 10.2174/0929866526666190730101455
 
Back
Top Bottom